- Home
- OGEN vs LGHL Comparison
OGEN vs LGHL Comparison
Compare OGEN & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- LGHL
- Stock Information
- Founded
- OGEN 1996
- LGHL 2015
- Country
- OGEN United States
- LGHL Singapore
- Employees
- OGEN N/A
- LGHL N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- LGHL Investment Bankers/Brokers/Service
- Sector
- OGEN Health Care
- LGHL Finance
- Exchange
- OGEN Nasdaq
- LGHL Nasdaq
- Market Cap
- OGEN 1.2M
- LGHL 1.2M
- IPO Year
- OGEN N/A
- LGHL N/A
- Fundamental
- Price
- OGEN $1.03
- LGHL $1.23
- Analyst Decision
- OGEN
- LGHL
- Analyst Count
- OGEN 0
- LGHL 0
- Target Price
- OGEN N/A
- LGHL N/A
- AVG Volume (30 Days)
- OGEN 112.5K
- LGHL 1.3M
- Earning Date
- OGEN 08-08-2025
- LGHL 09-16-2025
- Dividend Yield
- OGEN N/A
- LGHL N/A
- EPS Growth
- OGEN N/A
- LGHL N/A
- EPS
- OGEN N/A
- LGHL N/A
- Revenue
- OGEN N/A
- LGHL N/A
- Revenue This Year
- OGEN N/A
- LGHL N/A
- Revenue Next Year
- OGEN N/A
- LGHL N/A
- P/E Ratio
- OGEN N/A
- LGHL N/A
- Revenue Growth
- OGEN N/A
- LGHL N/A
- 52 Week Low
- OGEN $1.01
- LGHL $1.35
- 52 Week High
- OGEN $36.90
- LGHL $20.86
- Technical
- Relative Strength Index (RSI)
- OGEN 32.50
- LGHL 24.09
- Support Level
- OGEN $1.01
- LGHL $1.44
- Resistance Level
- OGEN $1.13
- LGHL $2.40
- Average True Range (ATR)
- OGEN 0.05
- LGHL 0.25
- MACD
- OGEN 0.04
- LGHL -0.05
- Stochastic Oscillator
- OGEN 26.32
- LGHL 0.02
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.